← Leaderboards
Kam W Leong
Johns Hopkins University
$23,208,213
Attributed
$34,072,400
Total exposure
23
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,072,400 · 23
By mechanism
R01$17,327,614 · 9
UH3$5,140,245 · 2
UG3$4,975,275 · 2
RM1$4,820,611 · 1
R21$984,454 · 3
P01$798,420 · 1
Top collaborators
- Soman N Abraham5 shared
- Henry Daniell5 shared
- Roland W. Herzog5 shared
- Bruce Alan Sullenger5 shared
- Nicholas Arpaia3 shared
- Tal Danino3 shared
- Mark Sascha Ansorge2 shared
- Kara Gross Margolis2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Fizan Abdullah$1,554,512
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsResponseNanoparticleBasePreventProteinsIn VivoTechnologyGenesPharmaceutical PreparationsSafetyChitosanAffectIn VitroBiodistributionTissuesMediatingToxic EffectTreatment EfficacyComplexOralSourceEngineeringStructure
Grant awards (64)
Differentiating the roles and underlying mechanisms of serotonin in the gut epithelium and ENS to create a novel drug delivery system to treat disorders of gut-brain interaction and mood dysfunction$646,980
R01 · FY2025 · DK
Programmable encapsulation systems to improve delivery of therapeutic bacteria$619,930
R01 · FY2025 · EB
Differentiating the roles and underlying mechanisms of serotonin in the gut epithelium and ENS to create a novel drug delivery system to treat disorders of gut-brain interaction and mood dysfunction$692,882
R01 · FY2024 · DK
Programmable encapsulation systems to improve delivery of therapeutic bacteria$617,386
R01 · FY2024 · EB
Endosomal mechanisms signaling oral cancer pain$4,820,611
RM1 · FY2023 · DE
Programmable encapsulation systems to improve delivery of therapeutic bacteria$613,945
R01 · FY2023 · EB
Focused Ultrasound-mediated Delivery of Gene-editing Elements to the Brain for Neurodegenerative Disorders$1,250,720
UH3 · FY2022 · NS · contact PI
Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screening$1,166,451
UH3 · FY2022 · TR · contact PI
Engineering Polymers to Scavenge DAMPs in Arthritis and Lupus$656,459
R01 · FY2022 · AR
Evaluation of nonviral gene editing systems in the brain assisted by focused ultrasound$321,741
UH3 · FY2022 · NS · contact PI
Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screening$1,189,483
UH3 · FY2021 · TR · contact PI
Focused Ultrasound-mediated Delivery of Gene-editing Elements to the Brain for Neurodegenerative Disorders$766,191
UG3 · FY2021 · NS · contact PI
Engineering Polymers to Scavenge DAMPs in Arthritis and Lupus$647,211
R01 · FY2021 · AR
Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screening$1,211,850
UH3 · FY2020 · TR · contact PI
Focused Ultrasound-mediated Delivery of Gene-editing Elements to the Brain for Neurodegenerative Disorders$782,568
UG3 · FY2020 · NS · contact PI
Engineering Polymers to Scavenge DAMPs in Arthritis and Lupus$671,248
R01 · FY2020 · AR
Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screening$1,178,937
UG3 · FY2019 · TR · contact PI
Focused Ultrasound-mediated Delivery of Gene-editing Elements to the Brain for Neurodegenerative Disorders$798,469
UG3 · FY2019 · NS · contact PI
Engineering Polymers to Scavenge DAMPs in Arthritis and Lupus$672,596
R01 · FY2019 · AR
Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screening$1,177,110
UG3 · FY2018 · TR · contact PI
Engineering Polymers to Scavenge DAMPs in Arthritis and Lupus$689,149
R01 · FY2018 · AR
Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screening$272,000
UG3 · FY2018 · TR · contact PI
Modeling Marfan Syndrome with iSMC-based Tissue-engineered Blood Vessel$120,000
R21 · FY2018 · HL · contact PI
Modeling Marfan Syndrome with iSMC-based Tissue-engineered Blood Vessel$120,000
R21 · FY2017 · HL · contact PI
Overcoming Immunosenescence by Nanoparticle-Mediated Activation$320,433
R01 · FY2016 · AI · contact PI
Oral Therapy for Hemophilia A$695,103
R01 · FY2015 · HL
Overcoming Immunosenescence by Nanoparticle-Mediated Activation$334,818
R01 · FY2015 · AI · contact PI
Oral Therapy for Hemophilia A$695,227
R01 · FY2014 · HL
Overcoming Immunosenescence by Nanoparticle-Mediated Activation$392,500
R01 · FY2014 · AI · contact PI
Oral Therapy for Hemophilia A$663,208
R01 · FY2013 · HL
Overcoming Immunosenescence by Nanoparticle-Mediated Activation$368,950
R01 · FY2013 · AI · contact PI
Derivation of Functional Neurons from Human Adult Cells by Nonviral Gene Delivery$185,064
R21 · FY2013 · EB · contact PI
Oral Therapy for Hemophilia A$692,419
R01 · FY2012 · HL
Overcoming Immunosenescence by Nanoparticle-Mediated Activation$392,500
R01 · FY2012 · AI · contact PI
Derivation of Functional Neurons from Human Adult Cells by Nonviral Gene Delivery$235,500
R21 · FY2012 · EB · contact PI
Oral Therapy for Hemophilia A$715,070
R01 · FY2011 · HL
Oral Nonviral Gene Delivery for Hemophilla A$419,047
R01 · FY2011 · HL · contact PI
IN VIVO CELL TARGETING / IMAGING WITH NEAR-IR-EMITTING DOPED ZNSE QUANTUM DOTS$6,136
P41 · FY2011 · RR · contact PI
EX VIVO MODEL TO STUDY NANOPARTICLE UPTAKE FOR ORAL GENE DELIVERY$6,136
P41 · FY2011 · RR · contact PI
Oral Nonviral Gene Delivery for Hemophilla A$421,982
R01 · FY2010 · HL · contact PI
EX VIVO MODEL TO STUDY NANOPARTICLE UPTAKE FOR ORAL GENE DELIVERY$5,460
P41 · FY2010 · RR · contact PI
Oral Nonviral Gene Delivery for Hemophilla A$425,935
R01 · FY2009 · HL · contact PI
Biomaterials Approach to Expand Hematopoietic Cells ex vivo$358,076
R01 · FY2009 · HL · contact PI
EX VIVO MODEL TO STUDY NANOPARTICLE UPTAKE FOR ORAL GENE DELIVERY$5,460
P41 · FY2009 · RR · contact PI
Oral Nonviral Gene Delivery for Hemophilla A$419,915
R01 · FY2008 · HL · contact PI
Biomaterials Approach to Expand Hematopoietic Cells ex vivo$358,074
R01 · FY2008 · HL · contact PI
Biofunctional fibers by polyelectrolyte complexation$284,078
R01 · FY2008 · EB · contact PI
TRACKING OF QUANTUM DOTS IN ORAL GENE DELLIVERY$2,589
P41 · FY2008 · RR · contact PI
Biomaterials Approach to Expand Hematopoietic Cells ex vivo$358,077
R01 · FY2007 · HL · contact PI
Biofunctional fibers by polyelectrolyte complexation$279,557
R01 · FY2007 · EB · contact PI
Mechanistic Studies on Polymeric Controlled Oral Gene$232,992
R01 · FY2007 · EB · contact PI
Biomaterials Approach to Expand Hematopoietic Cells ex vivo$368,773
R01 · FY2006 · HL · contact PI
Biofunctional fibers by polyelectrolyte complexation$287,053
R01 · FY2006 · EB · contact PI
Mechanistic Studies on Polymeric Controlled Oral Gene$252,043
R01 · FY2006 · EB · contact PI
Biofunctional fibers by polyelectrolyte complexation$292,725
R01 · FY2005 · EB
Mechanistic Studies on Polymeric Controlled Oral Gene$230,450
R01 · FY2005 · EB
Mechanistic Studies on Polymeric Controlled Oral Gene$25,797
R01 · FY2005 · EB
Mechanistic Studies on Polymeric Controlled Oral Gene$257,513
R01 · FY2004 · EB
Nanopatterned Biomaterials for Cellular Engineering$154,713
R21 · FY2004 · EB
Mechanistic Studies on Polymeric Controlled Oral Gene$257,513
R01 · FY2003 · EB
Nanopatterned Biomaterials for Cellular Engineering$169,177
R21 · FY2003 · EB
CONTROLLED RELEASE MICROSPHERES FOR RADIATION THERAPY$294,139
P01 · FY2002 · CA
CONTROLLED RELEASE MICROSPHERES FOR RADIATION THERAPY$294,139
P01 · FY2001 · CA
CONTROLLED RELEASE MICROSPHERES FOR RADIATION THERAPY$210,142
P01 · FY2000 · CA